PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12972984::ACT039562

MAVP

Evidence text

Paper-level observation

both MAVP and VAN treatments substantially attenuated calcium transients, while MAVP achieved the most pronounced pain signal suppression (Fig. 1L-N).
textConfidence: medium

Assay observation

Activity
Other
Subtype
Antibacterial
Measure
percent_inhibition
Comparator
=
Raw observation
most pronounced pain signal suppression; substantially attenuated calcium transients
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
RSC
Assay method
Not reported by source
Sequence
MAGGGATWLPPR
Standardization
ready simple

Source publication

Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

Bioactive Materials · 2026

DOI 10.1016/j.bioactmat.2026.03.009 PMC12972984
Parent mention

Related peptide identities

PEPDIA-PLP-001965

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.